Logos Global Management LP

CIK 0001792126 · Q1 2026

13F Equity AUM

$2.0B

+21.0% QoQ

Positions

-4 QoQ

AUM Rank

#1,795

Top 14%

Skill Alpha (FF)

+10.0%/yr^ns

No Clear Edge

Rank #300 · Top 4%

vs S&P -10.1%/yr (unadj.)

Quarters Tracked

~6 years

Portfolio Concentration

Top 5: 34.3%Top 10: 50.7%Top 20: 70.6%

RVMD9.7%

ERAS9.0%

IDYA5.7%

TERN5.3%

PRAX4.6%

CNTA4.2%

ABVX3.8%

TNGX3.1%

CYTK2.9%

OLMA2.4%

Others (53)49.3%

HHI (Herfindahl-Hirschman Index) measures portfolio concentration. Low (<1500) = diversified, Moderate (1500-2500), High (>2500) = concentrated bets.

Sector Allocation

Healthcare99.0%

Other1.0%

Portfolio weight by GICS sector based on latest 13F filing. Sectors below 2% are grouped as “Other.”

Position Sizing

Positions: 63Median: 0.97%Avg: 1.59%

0–0.5%

19(4.6%)

0.5–1%

13(10.2%)

1–3%

23(39.8%)

3–5%

4(15.7%)

5%+

4(29.7%)

Count of positions per weight bucket — (%) = combined portfolio weight

Loading summary cards...

Portfolio Overlap

Shared: 62Unique: 1vs 20 funds

0.8%Low

Fund positions

7,299

Consensus CUSIPs

Jaccard similarity of this fund’s portfolio vs the consensus of top 20 funds by AUM. Low (<15%) = contrarian, Moderate (15-40%), High (>40%) = follows the crowd.

Most Similar Funds

Top 9 benchmark funds with highest portfolio overlap (Jaccard similarity)

GEODE CAPITAL MANAGEMENT, LLC

1.7%

BlackRock, Inc.

1.4%

MORGAN STANLEY

1.1%

VANGUARD CAPITAL MANAGEMENT LLC

1.6%

FMR LLC

1.8%

STATE STREET CORP

1.5%

BANK OF AMERICA CORP /DE/

VANGUARD PORTFOLIO MANAGEMENT LLC

1.6%

JPMORGAN CHASE & CO

0.9%

Jaccard similarity per fund: shared CUSIPs / (fund A + fund B − shared). Higher values indicate more similar portfolios.

Loading overlap analysis...

Position Changes This Quarter

New11Increased23Decreased23Exited15

New Positions

UTH2.4%

+80K

MDGL2.2%

+85K

XENE1.3%

+450K

AVTX1.0%

+1.3M

ALKS0.6%

+350K

TENX0.5%

+625K

AVBP0.4%

+350K

RLAY0.4%

+750K

MGTX0.3%

+700K

VERADERMICS INC0.1%

+25K

Increased

CMPX0.8%

+2.0M(+174%)

CNTA4.2%

+1.9M(+963%)

TERN5.3%

+1.3M(+167%)

TRVI1.4%

+850K(+55%)

ELVN2.0%

+700K(+206%)

VOR0.7%

+650K(+650%)

IMCR2.3%

+650K(+76%)

TYRA1.6%

+640K(+305%)

CYTK2.9%

+575K(+192%)

ORIC0.6%

+500K(+111%)

Decreased

ERAS9.0%

-1,850,000(-14%)

TNGX3.1%

-1,200,000(-29%)

RVMD9.7%

-1,000,000(-33%)

IBIO0.1%

-700,000(-35%)

VSTM0.3%

-700,000(-41%)

DSGN1.0%

-550,000(-22%)

PCVX0.9%

-350,000(-54%)

IMVT1.3%

-300,000(-22%)

LBRX1.1%

-285,000(-24%)

AMLX0.5%

-250,000(-26%)

Exited

-310,000

-500,000

-200,000

-1,000,000

-675,000

KINIKSA PHARMACEUTIC…

-350,000

-130,000

-500,000

-850,000

-115,000

Quarter-over-quarter changes compared to prior 13F filing. New = first appearance; Exited = no longer held.

Loading position changes...

Holdings

Loading holdings...